Twilio (NYSE:TWLO – Get Free Report) was downgraded by Zacks Research from a “strong-buy” rating to a “hold” rating in a research note issued on Monday, Zacks reports. Several other equities analysts have also issued reports on TWLO. Wells Fargo & Company boosted their price target on shares of Twilio from $225.00 to $275.00 and […]

Mvb Financial (NASDAQ:MVBF – Get Free Report) was upgraded by investment analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a research note issued to investors on Monday, Zacks reports. Several other brokerages also recently weighed in on MVBF. TD Cowen upped their target price on shares of Mvb Financial […]

Zacks Research upgraded shares of Mvb Financial (NASDAQ:MVBF – Free Report) from a strong sell rating to a hold rating in a report released on Monday,Zacks reports. Other equities research analysts also recently issued research reports about the stock. TD Cowen raised their price objective on shares of Mvb Financial from $32.00 to $34.00 and […]

Ardent Health (NYSE:ARDT – Get Free Report) was upgraded by research analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a research note issued to investors on Monday, Zacks reports. Other equities analysts also recently issued research reports about the stock. Weiss Ratings downgraded shares of Ardent Health from a […]

PDD (NASDAQ:PDD – Get Free Report) was downgraded by equities research analysts at Arete Research from a “strong-buy” rating to a “hold” rating in a report issued on Monday, Marketbeat reports. They currently have a $93.00 target price on the stock. Arete Research’s price objective suggests a potential upside of 16.61% from the stock’s previous […]

Saratoga Investment (NYSE:SAR – Get Free Report) was upgraded by equities researchers at Zacks Research from a “strong sell” rating to a “hold” rating in a report issued on Monday, Zacks reports. Several other research analysts also recently weighed in on the stock. Weiss Ratings downgraded shares of Saratoga Investment from a “hold (c)” rating […]

Constellium (NYSE:CSTM – Get Free Report) was upgraded by research analysts at Zacks Research from a “hold” rating to a “strong-buy” rating in a research note issued on Monday, Zacks reports. A number of other brokerages have also recently weighed in on CSTM. Wells Fargo & Company upped their price objective on shares of Constellium […]

Zacks Research lowered shares of TG Therapeutics (NASDAQ:TGTX – Free Report) from a hold rating to a strong sell rating in a research note published on Monday,Zacks reports. Other equities analysts also recently issued reports about the stock. Jefferies Financial Group reaffirmed a “buy” rating and set a $83.00 target price on shares of TG […]